Diginex Limited Ordinary Shares (DGNX) has had the highest return since January 1, 2025 by a small-cap US stock, returning 1,240.8%.
| ASSET | % RETURN |
|---|---|
Diginex Limited Ordinary Shares (DGNX) | 1,240.85% |
Zepp Health (ZEPP) | 988.85% |
Relmada Therapeutics (RLMD) | 740.4% |
DeFi Development (DFDV) | 671.29% |
Palvella Therapeutics (PVLA) | 666.41% |
Nanobiotix (NBTX) | 618.49% |
Newegg Commerce (NEGG) | 614.5% |
NovaBay Pharmaceuticals (NBY) | 594.87% |
Avino Silver & Gold Mines (ASM) | 568.13% |
AXT (AXTI) | 568.02% |
Rich Sparkle Holdings Limited Ordinary Shares (ANPA) | 543.61% |
Americas Silver (USAS) | 510.53% |
Hycroft Mining (HYMC) | 478.32% |
DBV Technologies (DBVT) | 455.93% |
ThredUp (TDUP) | 453.47% |
Nutex Health (NUTX) | 448.8% |
Anbio Biotechnology Class A Ordinary Shares (NNNN) | 439.92% |
Almonty Industries Inc Common Shares (ALM) | 407.64% |
Inhibrx Biosciences (INBX) | 397.78% |
Galectin Therapeutics (GALT) | 396.95% |
Village Farms International (VFF) | 387.11% |
Integra Resources (ITRG) | 382.95% |
I-Mab (IMAB) | 378.82% |
Invivyd (IVVD) | 372.34% |
IsoEnergy (ISOU) | 337.97% |
Small-cap stocks are treated as having a market cap between $300M and $2B.
